Department of Cardiology, Aviation General Hospital, An Ding Men Wai Bei Yuan Road 3, Beijing 100012, China.
Cell Biochem Biophys. 2012 Dec;64(3):197-203. doi: 10.1007/s12013-012-9372-z.
This study aims to observe the effects of ibutilide on canine cardiac pacing threshold and on induction rates of atrial fibrillation. Eighteen mongrel dogs were anesthetized and administrated with ibutilide. The pacing thresholds and induction rates of atrial fibrillation were measured with and without ibutilide (10-min infusion dose was 0.10 mg kg(-1), followed by a maintaining dose of 0.01 mg min(-1) 30 min later). This study found that ibutilide increases pacing thresholds in dogs. Moreover, there were significant differences between pacing thresholds with and without ibutilide (P < 0.05). Further, ibutilide significantly reduces the induction rates of atrial fibrillation (P < 0.05). Our findings indicate that pacing voltage changes should be closely monitored in patients taking anti-arrhythmic drugs, who are treated with cardiac stimulation or have undergone pacemaker implantation. We also found that ibutilide is an effective drug in preventing or controlling atrial fibrillation.
本研究旨在观察伊布利特对犬心脏起搏阈值和心房颤动诱发率的影响。18 只杂种犬麻醉后给予伊布利特。测量有无伊布利特(10 分钟输注剂量为 0.10mg/kg,之后 30 分钟给予维持剂量 0.01mg/min)时的起搏阈值和心房颤动的诱发率。本研究发现伊布利特增加犬的起搏阈值。此外,有伊布利特和无伊布利特时起搏阈值有显著差异(P<0.05)。而且,伊布利特显著降低心房颤动的诱发率(P<0.05)。我们的研究结果表明,接受心脏刺激治疗或植入起搏器的心律失常患者,在使用抗心律失常药物时应密切监测起搏电压变化。我们还发现伊布利特是预防或控制心房颤动的有效药物。